{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Allegan",
      "state": "MI",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64729",
      "recalling_firm": "L. Perrigo Co.",
      "address_1": "515 Eastern Ave",
      "address_2": "N/A",
      "postal_code": "49010-9070",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-318-2013",
      "product_description": "Liothyronine Sodium Tablets, USP,  5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc.,  Minneapolis, MN 55427,  NDC 0574-0220-01,",
      "product_quantity": "21,667 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: 3 month stability testing.",
      "recall_initiation_date": "20130312",
      "center_classification_date": "20130509",
      "termination_date": "20130724",
      "report_date": "20130515",
      "code_info": "12K714 exp. 12/13, 12K715 exp. 12/13"
    }
  ]
}